135 related articles for article (PubMed ID: 35697957)
21. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
22. Preliminary validation of a structural magnetic resonance imaging metric for tracking dementia-related neurodegeneration and future decline.
Kress GT; Popa ES; Thompson PM; Bookheimer SY; Thomopoulos SI; Ching CRK; Zheng H; Hirsh DA; Merrill DA; Panos SE; Raji CA; Siddarth P; Bramen JE
Neuroimage Clin; 2023; 39():103458. PubMed ID: 37421927
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
24. Predicting the progression of mild cognitive impairment to Alzheimer's disease by longitudinal magnetic resonance imaging-based dictionary learning.
Lin Y; Huang K; Xu H; Qiao Z; Cai S; Wang Y; Huang L;
Clin Neurophysiol; 2020 Oct; 131(10):2429-2439. PubMed ID: 32829290
[TBL] [Abstract][Full Text] [Related]
25. Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
Vasta R; Augimeri A; Cerasa A; Nigro S; Gramigna V; Nonnis M; Rocca F; Zito G; Quattrone A; For The Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2016; 13(5):566-74. PubMed ID: 26787291
[TBL] [Abstract][Full Text] [Related]
26. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
27. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
28. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.
Wittens MMJ; Allemeersch GJ; Sima DM; Vanderhasselt T; Raeymaeckers S; Fransen E; Smeets D; de Mey J; Bjerke M; Engelborghs S
Neuroradiology; 2024 Apr; 66(4):487-506. PubMed ID: 38240767
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease.
Schmitter D; Roche A; Maréchal B; Ribes D; Abdulkadir A; Bach-Cuadra M; Daducci A; Granziera C; Klöppel S; Maeder P; Meuli R; Krueger G;
Neuroimage Clin; 2015; 7():7-17. PubMed ID: 25429357
[TBL] [Abstract][Full Text] [Related]
30. A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.
Sato R; Kudo K; Udo N; Matsushima M; Yabe I; Yamaguchi A; Tha KK; Sasaki M; Harada M; Matsukawa N; Amemiya T; Kawata Y; Bito Y; Ochi H; Shirai T
Eur Radiol; 2022 Jul; 32(7):4479-4488. PubMed ID: 35137303
[TBL] [Abstract][Full Text] [Related]
31. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
[TBL] [Abstract][Full Text] [Related]
32. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
Beheshti I; Demirel H; Matsuda H;
Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
Falgàs N; Balasa M; Bargalló N; Borrego-Écija S; Ramos-Campoy O; Fernández-Villullas G; Bosch B; Olives J; Tort-Merino A; Antonell A; Castellví M; Allen IE; Sánchez-Valle R; Lladó A
J Alzheimers Dis; 2020; 73(4):1575-1583. PubMed ID: 31958089
[TBL] [Abstract][Full Text] [Related]
34. Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia.
Persson K; Barca ML; Edwin TH; Cavallin-Eklund L; Tangen GG; Rhodius-Meester HFM; Selbæk G; Knapskog AB; Engedal K
Brain Behav; 2024 Feb; 14(2):e3397. PubMed ID: 38600026
[TBL] [Abstract][Full Text] [Related]
35. Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.
Hedderich DM; Spiro JE; Goldhardt O; Kaesmacher J; Wiestler B; Yakushev I; Zimmer C; Boeckh-Behrens T; Grimmer T
J Alzheimers Dis; 2018; 65(4):1459-1467. PubMed ID: 30175976
[TBL] [Abstract][Full Text] [Related]
36. Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
Kim REY; Lee M; Kang DW; Wang SM; Kim D; Lim HK
J Alzheimers Dis; 2024; 97(1):259-271. PubMed ID: 38143346
[TBL] [Abstract][Full Text] [Related]
37. An optimal decisional space for the classification of Alzheimer's disease and mild cognitive impairment.
Zhou Q; Goryawala M; Cabrerizo M; Wang J; Barker W; Loewenstein DA; Duara R; Adjouadi M
IEEE Trans Biomed Eng; 2014 Aug; 61(8):2245-53. PubMed ID: 25051543
[TBL] [Abstract][Full Text] [Related]
38. AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
Mai Y; Yu Q; Zhu F; Luo Y; Liao W; Zhao L; Xu C; Fang W; Ruan Y; Cao Z; Lei M; Au L; Mok VCT; Shi L; Liu J
J Alzheimers Dis; 2021; 79(3):1023-1032. PubMed ID: 33459705
[TBL] [Abstract][Full Text] [Related]
39. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
Misra C; Fan Y; Davatzikos C
Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
